Yanli Ju1, Hongwei Zhang2, Miaoling Chen3, Xu Chi4, Wei Lan4, Honglei Zhang4, Jingfang Mo5, Ng Yuen Yung6. 1. Peking University of Shenzhen Hospital, Shenzhen, Guangdong Province, China. Electronic address: juyanlihk@gmail.com. 2. School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong. 3. Peking University of Shenzhen Hospital, Shenzhen, Guangdong Province, China; Medical College of Shantou University, Shantou, Guangdong Province, China; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China. 4. Peking University of Shenzhen Hospital, Shenzhen, Guangdong Province, China. 5. Hong Kong Baptist University, Hong Kong. 6. Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Abstract
OBJECTIVE: To investigate the effect of auricular stimulation in cavum conchae on the glycemic control for patients with type 2 diabetes mellitus. METHODS: Seventy-one cases were treated with auricular electrical stimulator in the cavum choncha for 30 min, once daily for consecutive 3 months. The changes on the fasting plasma glucose (FBG), 2-h postprandial blood glucose after a 75 g oral glucose load (P2BG), glycated hemoglobin (HbA1c), blood urea nitrogen (BUN), serum creatinine (SCr), total cholesterol (TC) and aspartate transaminase (AST) were compared before and after the treatment. RESULTS: The level of the HbA1c was significantly decreased (P<0.05), and there were also statistically significant decreases in BUN, SCr, TC and AST after the treatment (P<0.05). A few patients (n=7) reduced the dose of the hypoglycemic agents in response to repeated hypoglycemia during the treatment. CONCLUSION: The stimulation in the cavum conchae of patients with types 2 diabetes mellitus may help decrease HbA1c, BUN, SCr, TC and AST, and may be an effective treatment for type 2 diabetes mellitus.
OBJECTIVE: To investigate the effect of auricular stimulation in cavum conchae on the glycemic control for patients with type 2 diabetes mellitus. METHODS: Seventy-one cases were treated with auricular electrical stimulator in the cavum choncha for 30 min, once daily for consecutive 3 months. The changes on the fasting plasma glucose (FBG), 2-h postprandial blood glucose after a 75 g oral glucose load (P2BG), glycated hemoglobin (HbA1c), blood ureanitrogen (BUN), serum creatinine (SCr), total cholesterol (TC) and aspartate transaminase (AST) were compared before and after the treatment. RESULTS: The level of the HbA1c was significantly decreased (P<0.05), and there were also statistically significant decreases in BUN, SCr, TC and AST after the treatment (P<0.05). A few patients (n=7) reduced the dose of the hypoglycemic agents in response to repeated hypoglycemia during the treatment. CONCLUSION: The stimulation in the cavum conchae of patients with types 2 diabetes mellitus may help decrease HbA1c, BUN, SCr, TC and AST, and may be an effective treatment for type 2 diabetes mellitus.
Authors: Eugenijus Kaniusas; Stefan Kampusch; Marc Tittgemeyer; Fivos Panetsos; Raquel Fernandez Gines; Michele Papa; Attila Kiss; Bruno Podesser; Antonino Mario Cassara; Emmeric Tanghe; Amine Mohammed Samoudi; Thomas Tarnaud; Wout Joseph; Vaidotas Marozas; Arunas Lukosevicius; Niko Ištuk; Antonio Šarolić; Sarah Lechner; Wlodzimierz Klonowski; Giedrius Varoneckas; Jozsef Constantin Széles Journal: Front Neurosci Date: 2019-08-09 Impact factor: 4.677